Bioterrorism-Related Webcasts from the Third International Conference on Emerging Infectious Diseases (ICEID 2002)
Webcasts by CDC Presenters
-
An
Anthrax Outbreak Averted: Public Health Response to a Contaminated
Envelope on Capitol Hill, Washington, DC, 2001
Vincent Hsu, CDC, Atlanta, GA
March 26, 2002 -
Anthrax
in the US Postal System
Michele Pearson, CDC, Maryland
March 26, 2002 -
Bioterrorism
Preparedness: Lessons, Challenges, and Opportunities
James Hughes, CDC, Atlanta, GA
March 25, 2002 -
Importance
of Bacillus anthracis Molecular Subtyping During the
Recent Multi-State Bioterrorism-Associated Anthrax Outbreak
in the United States
Alex Hoffmaster, CDC, Atlanta, GA
March 26, 2002 -
Inhalational
Anthrax—New York City, October–November 2001
Timothy Holtz, CDC and New York City Department of Health, New York, NY
March 26, 2002 -
Letters
from Trenton: The Anthrax Investigation at the Source, New Jersey,
2001
Jennita Reefhuis, CDC, Atlanta, GA
March 26, 2002 -
Rapid
Adaptation of a Serologic Assay for the Bioterrorism-Related
Anthrax Outbreak—October–December, 2001
Carolyn Greene, CDC, Atlanta, GA
March 26, 2002 -
Smallpox
Vaccine and Vaccination Strategies
Joanne Cono, CDC, Atlanta, GA
March 25, 2002 -
Virology
and Diagnosis of Smallpox
Russell Regnery, CDC, Atlanta, GA
March 25, 2002 -
Webcasts by Non-CDC Presenters
-
Bioterrorism [Public Health Policy/Law]
Richard Hoffman, Colorado Department of Public Health and Environment, Denver, CO
March 25, 2002 -
Bioterrorism
2001: Lessons Learned
Leonard Cole, Department of Political Science, Rutgers University, Newark, NJ
March 26, 2002 -
BT
Surveillance in NYC
Farzad Mostashari, Bureau of Communicable Disease, New York City Department of Health, New York, NY
March 25, 2002 -
Clinical
and Epidemiologic Features of Smallpox
Stanley Foster, Rollins School of Public Health, Emory University, Atlanta, GA
March 25, 2002 -
Clinical
Management of Smallpox Patients
Peter L. Havens, Medical College of Wisconsin, Milwaukee, WI
March 25, 2002 -
Cutaneous
Anthrax in New York City
Marcelle Layton, New York Department of Health, New York, NY
March 26, 2002 -
Enhanced
Emergency Department Surveillance System Following the World
Trade Disaster—New York City, September 14 to October 10,
2001
Debjani Das, New York Department of Health, New York, NY
March 25, 2002 -
Inhalation
Anthrax in Florida
Steve Wiersma, Florida Department of Health, Tallahassee, FL
March 26, 2002 -
Inhalation
Anthrax of Unknown Source
James Hadler, Connecticut Department of Public Health, Hartford, CT
March 26, 2002 -
Laboratory
Response in the Commonwealth of Virginia to the Intentional
Release of Bacillus anthracis
Denise Pettit, Division of Consolidated Laboratory Services, Richmond, VA
March 25, 2002 -
Public
Health Laboratory Response to an Anthrax Incident in Connecticut
Donald Mayo, Connecticut State Health Department, Hartford, CT
March 25, 2002 -
Rapid
Molecular Identification of B. anthracis in New York
State in Response to Recent Bioterrorism Incidents
Kimberlee Musser, New York, State Department of Health, Albany, NY
March 25, 2002 -
Surveillance
of Livestock for Zoonotic Diseases and Veterinary Bio-Threat
Agents
William Hueston, College of Veterinary Medicine, University of Minnesota, St. Paul, MN
March 25, 2002 -
The
Role of Healthcare Systems in Bioterrorism Preparedness
Trish Perl, Johns Hopkins Hospital, Baltimore, MD
March 26, 2002 -
Threat
Letter Menace: The Fiji Experience
Kamal Kishore, Fiji School of Medicine, Suva, Fiji
March 25, 2002
Note: the views expressed by non-CDC presenters do not necessarily represent the views of CDC. Links to these webcasts are provided solely as a service to our users. These links do not indicate an endorsement of the presenters, their organizations, or any commercial products by CDC.
Anthrax
Vaccines
Arthur Friedlander, U.S. Army Medical Research
Institute of Infectious Diseases, Fort Detrick, MD
March 27, 2002